These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7603746)

  • 1. Messages and handshakes: cellular interactions in pulmonary fibrosis.
    Kumar RK; Lykke AW
    Pathology; 1995 Jan; 27(1):18-26. PubMed ID: 7603746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.
    Prasse A; Pechkovsky DV; Toews GB; Jungraithmayr W; Kollert F; Goldmann T; Vollmer E; Müller-Quernheim J; Zissel G
    Am J Respir Crit Care Med; 2006 Apr; 173(7):781-92. PubMed ID: 16415274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of lung fibroblast proliferation by macrophage-derived platelet-derived growth factor.
    Brody AR
    Ann N Y Acad Sci; 1994 May; 725():193-9. PubMed ID: 8030989
    [No Abstract]   [Full Text] [Related]  

  • 4. Bleomycin-induced pulmonary fibrosis in hamsters. An alveolar macrophage product increases fibroblast prostaglandin E2 and cyclic adenosine monophosphate and suppresses fibroblast proliferation and collagen production.
    Clark JG; Kostal KM; Marino BA
    J Clin Invest; 1983 Dec; 72(6):2082-91. PubMed ID: 6196378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of pulmonary fibrosis and current treatment.
    Kuwano K; Hagimoto N; Hara N
    Curr Mol Med; 2001 Nov; 1(5):551-73. PubMed ID: 11899231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal.
    Wynes MW; Frankel SK; Riches DW
    J Leukoc Biol; 2004 Nov; 76(5):1019-27. PubMed ID: 15316031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease?
    Byrne AJ; Maher TM; Lloyd CM
    Trends Mol Med; 2016 Apr; 22(4):303-316. PubMed ID: 26979628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: a review.
    Zhou BW; Liu HM; Xu F; Jia XH
    Cell Commun Signal; 2024 Mar; 22(1):172. PubMed ID: 38461312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paired immunoglobulin-like receptor-B inhibits pulmonary fibrosis by suppressing profibrogenic properties of alveolar macrophages.
    Karo-Atar D; Moshkovits I; Eickelberg O; Königshoff M; Munitz A
    Am J Respir Cell Mol Biol; 2013 Apr; 48(4):456-64. PubMed ID: 23258232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Growth factors in the process of inflammation and fibrosis in the lung].
    Matsuse T
    Nihon Kokyuki Gakkai Zasshi; 1998 May; 36(5):413-20. PubMed ID: 9742856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell Cross-Talk in Alveolar Microenvironment: From Lung Injury to Fibrosis.
    Song L; Li K; Chen H; Xie L
    Am J Respir Cell Mol Biol; 2024 Jul; 71(1):30-42. PubMed ID: 38579159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis of idiopathic pulmonary fibrosis].
    Buhl R; Meier-Sydow J; Vogelmeier C
    Immun Infekt; 1995 Jun; 23(3):92-6. PubMed ID: 7615308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electron microscopic studies on pathogenesis of idiopathic pulmonary fibrosis].
    Tang X; He B; Li G; Zhang H; Chai L
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jan; 22(1):27-9. PubMed ID: 11812351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of cytokines in pulmonary fibrosis].
    Ogushi F
    Nihon Ika Daigaku Zasshi; 1996 Oct; 63(5):391-4. PubMed ID: 8937127
    [No Abstract]   [Full Text] [Related]  

  • 15. [MODIFICATION OF ALVEOLAR MACROPHAGE POOL UNDER INFLUENCE OF PEPTIDE THERAPY IN THE BLEOMYCIN PNEUMOFIBROSIS MODEL].
    Lebedeva ES; Dvorakovskava IV; Kuzubova NA; Titova ON
    Ross Fiziol Zh Im I M Sechenova; 2015 Dec; 101(12):1394-402. PubMed ID: 26987231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury.
    Henke C; Marineili W; Jessurun J; Fox J; Harms D; Peterson M; Chiang L; Doran P
    Am J Pathol; 1993 Oct; 143(4):1189-99. PubMed ID: 7692734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alveolar macrophage stimulation of lung fibroblast growth in asbestos-induced pulmonary fibrosis.
    Lemaire I; Beaudoin H; Massé S; Grondin C
    Am J Pathol; 1986 Feb; 122(2):205-11. PubMed ID: 3946556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages.
    Uhal BD; Kim JK; Li X; Molina-Molina M
    Curr Pharm Des; 2007; 13(12):1247-56. PubMed ID: 17504233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural study on human lung in alveolitis versus pulmonary fibrosis.
    Fischer B; Morgenroth K
    Clin Investig; 1993 Jun; 71(6):452-60. PubMed ID: 8353404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway.
    Wygrecka M; Dahal BK; Kosanovic D; Petersen F; Taborski B; von Gerlach S; Didiasova M; Zakrzewicz D; Preissner KT; Schermuly RT; Markart P
    Am J Pathol; 2013 Jun; 182(6):2094-108. PubMed ID: 23562441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.